Latest Development

Voriconazole is a triazole antifungal medication used to treat serious fungal infections. The primary mode of action of Voriconazole is the inhibition of fungal cytochrome P450 mediated 14 alpha-lanosterol demethylation, an essential step in fungal ergosterol biosynthesis. Votab is available as 200 mg tablet in 1 × 10 alu-alu blister pack. 222

Visican 50 ml Solution for injection, a preparation of Iodixanol 320 mg organic iodine/ ml Iso-Osmolarity Contrast media is a safest contrast for renal impairment, diabetic, high creatinine level, and cardiovascular disease patients. Iodixanol Used to arteriography’s, angiocardiography, selected coronary arteriography, CT scan, Urography & CCTA (Coronary CT Angiography) for clear Diagnosis. Visican 320 is available as 1 vial of Visican 320 Injection 50 ml in a box. It is launched on April 20, 2024.

Glipatab-M tablet is a combination of two oral anti-hyperglycemic drugs, Empagliflozin and Metformin. Empagliflozin and Metformin combination has been approved by the US Food and Drug Administration for the treatment of type 2 diabetes mellitus (T2DM). Glipatab-M ensures glycemic control by multiple ways with targeted benefit. It effectively reduces Fasting Plasma Glucose (FPG) and HbA1c. Glipatab-M is beneficial for T2DM patients with CVD, CKD & obesity. It is available as 5/500 mg Tablet in Alu-Alu blister pack. It is Launched on March 15, 2024.

Bilamin Kids is a preparation of Bilastine INN 10 mg Orodispersible Tablet, which is specially designed for patients aged 6-11 years. Swallowing tablet is difficult for children, but Bilamin kids will be dissolved in mouth within 45 seconds. Bilastine is a fully non-sedative antihistamine with higher safety and efficacy. It shows moderate to high affinity for histamine H1-receptors and no affinity for muscarinic, serotonergic, dopaminergic and noradrenergic receptors. Bilamin Kids is available as 3x10 ODT in alu-alu blister pack. Bilamin 20 mg Tablet and Bilamin 12.5 mg/ 5 ml Oral Solution are also available. It is launched on May 05, 2024.

Lopitrast (Iopamidol), an organic Iodine compound and used as a non-ionic water-soluble radiographic contrast medium. Iopamidol blocks X-rays as they pass through the body, thereby allowing body structures not containing Iodine to be visualized. The degree of opacity produced by lopamidol is directly proportional to the total amount of the iodinated contrast agent in the path of the X-rays. The visualization of body structures is dependent upon the distribution and elimination of lopamidol. Lopitrast is available as –Lopitrast 370: (50 ml): Each glass bottle contains 37.76 g of lopamidol equivalent to 370 mg of Iodine per ml. Lopitrast 370: (100 ml): Each glass bottle contains 75.52 g of lopamidol equivalent to 370 mg of Iodine per ml. It is launched on May 20, 2024.

Linax E tablet is a combination of two oral antihyperglycemic drugs, Linagliptin and Empagliflozin. Linagliptin and Empagliflozin single-tablet combination (STC) has been recently approved by the US Food and Drug Administration for the treatment of type 2 diabetes mellitus (T2DM). Linax E, the power of 2 proven antidiabetics medicines, taking once daily works in 3 ways. It effectively lowers FPG and HbA1c. It is an effective option for T2DM patients with CKD. Linax E is a safe and effective option for T2DM patients who are not recommended to take Metformin due to intolerance and renal impairment and have a higher baseline HbA1c.It is available as 5/10 mg & 5/25 mg Tablet. It is launched on June 06, 2024.

Gadosol 10 ml solution for injection, a preparation of Gadoteric Acid is a unique contrast agent indicated for intravenous use with magnetic resonance imaging (MRI) in brain (intracranial), spine and associated tissues in adult and pediatric patients (2 years of age and older) to detect and visualize areas with disruption of the blood brain barrier (BBB) and/or abnormal vascularity. Gadosol solution for injection is available as 1 X 10 vials in a box. Gadosol 10 ml solution for injection is the first time locally manufactured Gadoteric Acid in Bangladesh. Gadosol solution for injection is launched on June 06, 2024.

Bilamin Oral Solution is a preparation of Bilastine INN 12.5 mg/5 ml Syrup, which is suitable for patients aged 2-11 years. Due to excellent vanilla flavor, it will be very desirable for children. Bilastine is a fully non-sedative antihistamine with higher safety and efficacy. Bilastine has been demonstrated to have limited distribution to the brain following oral administration. Bilamin Oral Solution is available as 60 ml Syrup in amber PET bottle. Bilamin 20 mg Tablet and Bilamin Kids are also available. It is launched on June 05, 2024.

Moringa LX Capsule is the preparation of Moringa oliefera leaf extract. Moringa leaf extract is a natural nutritional supplement that is enriched with proteins, vitamins, minerals and essential amino acids. It contains 90 nutrients and 46 antioxidants. It is an excellent source of vitamin A, vitamin B, vitamin C, vitamin E, iron, protein, fiber, calcium, magnesium, potassium & phosphorus. It also contains different types of active phytochemicals like quercetin, isothiocyanate, kaemferol, arginine, niaziminin, glycosides, alkaloids, quinine, saponins, flavonoids, tannin, steroids and fixed oil responsible for pharmacological action. Moringa LX Capsule is indicated for, Malnutrition & Anemia, Lowers blood sugar level, Decreases hyperlipidemia, Helps in weight management and Increases energy & body immunity. It is Launched on June 25, 2024.

Xorel MUPS 20 mg Tablet is the preparation of Rabeprazole Sodium USP 20 mg. MUPS tablet ensures rapid and uniform gastric emptying and subsequently uniform drug dissolution of pellets in the gastrointestinal tract due to their small size and larger surface. Uniform drug absorption is facilitated which results in consistent and controlled pharmacological action. Xorel MUPS Tablet is indicated for, Gastric Ulcer, Peptic Ulcer, Duodenal Ulcers, NSAID Induced Ulcer, GERD, Heartburn, Zollinger-Ellison Syndrome and Helicobacter pylori Eradication etc. It is launched on Feb 06, 2024.

Esolok MUPS 20 & 40 mg Tablet is the preparation of Esomeprazole 20 & 40 mg. MUPS tablet ensures rapid and uniform gastric emptying and subsequently uniform drug dissolution of pellets in the gastrointestinal tract due to their small size and larger surface. Uniform drug absorption is facilitated which results in consistent and controlled pharmacological action. Esolok MUPS Tablet is indicated for, GERD, Heartburn, Gastric Ulcer, Peptic Ulcer, Duodenal Ulcers, NSAID Induced Ulcer, GERD, Zollinger-Ellison Syndrome and Helicobacter pylori Eradication etc. It is launched on April 05, 2024.

Vonoprazan is a potassium-competitive acid blocker (P-CAB) and does not require activation by acid. It inhibits H+, and K+-ATPase in a reversible and potassium-competitive manner. Vonoprazan has strong basicity and resides on the acid production site of gastric parietal cells for a long time, thereby inhibiting gastric acid production. Vonoprazan exerts a strong inhibitory effect on the formation of mucosal damage in the upper part of the gastrointestinal tract.

Sucrasol Suspension is a sucrose sulfate-aluminium complex that binds to the ulcer, creating a physical barrier that protects the gastrointestinal tract from stomach acid and prevents the degradation of mucus. The action of Sucrasol is non-systemic. Sucrasol is indicated in adults and adolescents over 14 years old for treatment of duodenal ulcer, gastric ulcer, chronic gastritis and the prophylaxis of gastrointestinal hemorrhage from stress ulceration in seriously ill patients. Sucrasol is available as oral suspension in 200 ml PET bottle.

Salbutamol is a synthetic sympathomimetic agent with predominant beta-2 adrenergic activity. Salbutamol produces bronchodilatation through stimulation of beta-2-adrenergic receptors in bronchial smooth muscles, thereby causing relaxation of bronchial muscle fibers.Salbutamol cozycap is indicated both for treatment and prophylaxis of bronchospasm in bronchial and exercise-induced asthma in patients 4 years of age and older, and also for treatment of other conditions, such as bronchitis and emphysema associated with reversible airways obstruction. Each box contains 3x10 Cozycaps in Alu-Alu blister pack for use with CapHaler Device.

Pertrum Tablet combines two analgesics ; Tramadol and Paracetamol which is highly effective than monotherapy. Tramadol a centrally acting analgesic with a unique dual mechanism of action: Tramadol works for pain management by binding with μ-opioid receptors in the CNS, essentially blocking pain signals from reaching the brain, and also by inhibiting the reuptake of neurotransmitters like Serotonin and Norepinephrine which further contributes to pain relief. Paracetamol is a non-opiate, non-salicylate analgesic. Paracetamol blocks the production prostaglandin synthesis in the body that are responsible for pain and fever. The analgesic of choice for mild to moderate pain and to reduce fever. Peratrum Tablet a more potent analgesic than oral NSAIDs.

Rsudil Plus Eye Drops : Each ml sterile ophthalmic solution contains Netarsudil dimesylate INN 0.20 mg and Latanoprost USP 0.05 mg.This is a fixed-dose combination of a Rho kinase inhibitor and a Prostaglandin F2 analogue. Netarsudil is a Rho kinase inhibitor, works at the cellular level within the trabecular outflow pathway to relax actin-myosin. This causes relaxation within the trabecular meshwork and the inner wall of Schlemm's canal, and decrease episcleral venous pressure (EVP). Latanoprost is a selective FP receptor agonist which reduces the intraocular pressure (IOP) by increasing the outflow of aqueous humor through uveoscleral outflow.Rsudil Plus is indicated for the treatment of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension.

Polygel Eye Gel: Each gram eye gel contains Polyethylene Glycol 400 USP 4 mg & Propylene Glycol USP 3 mg.Polyethylene Glycol & Propylene Glycol protect eyes from discomfort associated with dry eye so that the eyes feel moist and refreshed for a long period. The combination of Polyethylene Glycol & Propylene Glycol is clinically proven to reduce both signs and symptoms of dry eye. The mechanism of action is thought to be due to its unique gelling and lubricating system formulated to adjust to each user's individual tear pH. When the ingredients of this eye drops combine with natural tears, a soft gel forms a network of protection over the eye surface. Since it promotes a healthy environment in eye surface, damaged surface cells of eye can repair more easily. Indicated for the temporary relief of burning and irritation due to dryness of the eye.

Gavisol Kids is a preparation of Sodium Alginate & Magnesium Alginate. It works in the physical mode of action and does not enter into the systemic circulation. Sodium Alginate & Magnesium Alginate reacts rapidly with gastric acid to form a thickening gel, one that stabilizes the stomach contents and reduces gastric reflux & regurgitation. Gavisol Kids is available as 20 sachets in a box.

Teltab-80 is a preparation of Telmisartan. Telmisartan is a Angiotensin Receptor Blocker (ARB). It blocks the vasoconstriction and aldosterone-secreting effects of angiotensin II by selectively blocking the binding of angiotensin II to the AT1 receptor in many tissues, such as vascular smooth muscle and the adrenal gland. It's action is therefore, independent of the pathways for angiotensin II synthesis. Telmisartan has much greater affinity (>3,000 fold) for the AT1 receptor than for the AT2 receptor. As Telmisartan does not inhibit ACE (kininase II), it does not affect the response to bradykinin. Telmisartan does not bind to or block other hormone receptors or ion channels known to be important in cardiovascular regulation. Teltab is used for the treatment of essential hypertension in adults. It is launched on June 13, 2025.

Olmetab-40 is a preparation of Olmesartan Medoxomil. Olmesartan Medoxomil, a prodrug, is hydrolyzed to Olmesartan during absorption from the gastrointestinal tract. Olmesartan is an Angiotensin Receptor Blocker (ARB). It blocks the vasoconstriction and aldosterone-secreting effects of angiotensin II by selectively blocking the binding of angiotensin II to the AT1 receptor in many tissues, such as vascular smooth muscle and the adrenal gland. Olmetab is used for the treatment of essential hypertension in adults. It is launched on May 23, 2025.

Finotab tablet is a preparation of Finerenone. It is a novel non-steroidal selective & highly potent mineralocorticoid receptor antagonist.Finerenone has been recently approved by the US Food and Drug Administration for the treatment of reducing the risk of sustained eGFR decline, end stage kidney disease, cardiovascular death, non-fatal myocardial infarction, and hospitalization for heart failure in adult patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2D). FINOTAB: A Novel Therapy for Cardio-Renal Protection, taking once daily blocks MR mediated sodium reabsorption and MR over activation in both epithelial (e.g., kidney) and nonepithelial (e.g., heart, and blood vessels) tissues. As a result, it helps to reduce the progression of chronic kidney disease (CKD) and cardiovascular (CV) risks. FINOTAB is a safe and effective option without sexual side effects and less chance of hyperkalemia. It is available as 10 mg tablet. It is launched on July 14, 2025.